☰

David C. Seldin

Affiliations: 
Boston University, Boston, MA, United States 
Area:
Biochemistry, Oncology
Google:
"David Seldin"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Padmalatha Channavajhala grad student 2001 Boston University
Diane H. Song grad student 2001 Boston University
Esther Landesman-Bollag grad student 2002 Boston University
Gregory A. Imbrie grad student 2006 Boston University
David Y. Lou grad student 2006 Boston University
Jennifer E. Ward grad student 2006 Boston University
Marganit Farago grad student 2007 Boston University
Nicolas V. Currier grad student 2008 Boston University
Beth M. Hovey grad student 2010 Boston University
Jian Guan grad student 2012 Boston University

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zhou Y, Lian H, Shen N, et al. (2020) The multifaceted role of protein kinase CK2 in high-risk acute lymphoblastic leukemia. Haematologica
Lian H, Li D, Zhou Y, et al. (2016) CK2 inhibitor CX-4945 destabilizes NOTCH1 and synergizes with JQ1 against human T-acute lymphoblastic leukemic cells. Haematologica
Lee SY, Meehan RS, Seldin DC, et al. (2016) Effect of severe hypoalbuminemia on toxicity of high-dose melphalan and autologous stem cell transplantation in patients with AL amyloidosis. Bone Marrow Transplantation
Stanford EA, Wang Z, Novikov O, et al. (2016) The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells. Bmc Biology. 14: 20
Gertz MA, Landau H, Comenzo RL, et al. (2016) First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Sissoko M, Sanchorawala V, Seldin D, et al. (2015) Clinical presentation and treatment responses in IgM-related AL amyloidosis. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 1-7
Sanchorawala V, Sun F, Quillen K, et al. (2015) Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20 year experience. Blood
Guan J, Mishra S, Qiu Y, et al. (2015) Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity. Embo Molecular Medicine. 7: 688
Sanchorawala V, Brauneis D, Shelton AC, et al. (2015) Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 1445-51
Liedtke M, Merlini G, Landau HJ, et al. (2015) The VITAL study: A randomized, double-blind, placebo-controlled, global, phase III study of NEOD001 in patients with AL amyloidosis and cardiac dysfunction. Journal of Clinical Oncology. 33: 8614-8614
See more...